Security Snapshot

EyePoint, Inc. - Common Stock (EYPT) Institutional Ownership

CUSIP: 30233G209

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

187

Shares (Excl. Options)

92.82MFull value: 92,818,559 · shares · 30 Jun 2026

Price

$14.30

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,407,515
Value change
+$50,204,790
Number of holders
187
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
86,286,333
SEC-reported price per share
$3.07
Insider filing price
$3.07
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • EYPT - EyePoint, Inc. - Common Stock is tracked under CUSIP 30233G209.
  • 187 institutions reported positions in Q2 2026.
  • 12 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 187 to 187 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $1.15BFull value: $1,149,112,955 · USD · 31 Mar 2026
    to
    $1.33BFull value: $1,327,112,039 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 187 institutions filings for Q2 2026.

Open SEC evidence

Security key

30233G209

13F reference period

Q2 2026

13F holders

187

13D/G owners

12

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
12
Security
EYPT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Janus Henderson Group Ltd. 11% $112,021,331 9,366,332 JANUS HENDERSON GROUP Ltd. 31 Aug 2026
TANG CAPITAL MANAGEMENT LLC 9.6% $26,978,154 8,250,200 TANG CAPITAL MANAGEMENT, LLC 20 Oct 2026
Cormorant Asset Management, LP 8.4% -16% $98,140,000 -$17,735,300 7,000,000 -15% Cormorant Asset Management, LP 30 Jun 2026
FEDERATED HERMES, INC. 8% +19% $22,698,417 +$7,643,038 6,934,414 +51% Federated Hermes, Inc. 30 Sep 2026
BlackRock, Inc. 7.7% +17% $91,955,821 +$27,814,572 6,430,477 +43% BlackRock, Inc. 30 Jun 2026
Adage Capital Management, L.P. 5.7% +44% $67,166,904 +$20,900,904 4,790,792 +45% Adage Capital Management, L.P. 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5% -0.8% $14,079,600 +$269,033 4,305,688 +1.9% Vanguard Capital Management 30 Sep 2026
Commodore Capital LP 5.1% $57,077,500 4,250,000 Commodore Capital LP 27 May 2026
FRANKLIN RESOURCES INC 6.1% -18% $27,059,688 +$820,894 4,137,567 +3.1% Franklin Resources, Inc. 31 Dec 2024
TCG Crossover GP II, LLC 4.3% $62,265,799 3,572,335 TCG Crossover GP II, LLC 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P. 4.7% $20,809,090 3,181,818 RA Capital Management, L.P. 31 Dec 2024
Paradigm Biocapital Advisors LP 3.8% -26% $44,591,181 -$14,897,003 3,142,437 -25% Paradigm BioCapital Advisors LP 31 Mar 2026
As of 30 Jun 2026, 187 institutional investors reported holding
92.82MFull value: 92,818,559 · shares · 30 Jun 2026
shares of EyePoint, Inc. - Common Stock (EYPT). This represents 108% of the company’s total
86.29MFull value: 86,286,333 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
85%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MONTANOVA CAPITAL, LLC 9.6% 8,296,375 0% 2.5% $118,638,163
BlackRock, Inc. 8.6% 7,463,197 +4% 0% $106,723,718
Cormorant Asset Management, LP 8.1% 7,000,000 -15% 5.1% $100,100,000
FEDERATED HERMES, INC. 6.6% 5,681,052 +0.2% 0.12% $81,239,044
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.6% 4,827,792 +46% 0.1% $69,037,426
FRANKLIN RESOURCES INC 5.6% 4,807,078 -4.8% 0.01% $68,741,215
Commodore Capital LP 5.3% 4,600,000 +63% 3.9% $65,780,000
Jupiter Topco LLC 4.4% 3,770,381 0% 0.02% $53,897,596
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 3,630,252 +2% 0% $51,912,604
Paradigm Biocapital Advisors LP 3.3% 2,890,397 -8% 0.77% $41,332,677
STATE STREET CORP 2.7% 2,357,545 +12% 0% $33,712,894
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,062,390 +4% 0% $29,497,382
Aberdeen Group plc 2.3% 2,008,802 +16% 0.04% $28,725,869
CITADEL ADVISORS LLC 2.3% 1,977,610 +3.8% 0.02% $28,279,823
Balyasny Asset Management L.P. 2.1% 1,812,358 +26% 0.05% $25,916,719
Parkman Healthcare Partners LLC 1.5% 1,288,163 -4.9% 1.9% $18,420,731
EVENTIDE ASSET MANAGEMENT, LLC 1.4% 1,245,583 0% 0.24% $17,811,837
TWO SIGMA INVESTMENTS, LP 1.4% 1,181,143 +174% 0.01% $16,890,345
Essex Woodlands Management, Inc. 1.3% 1,084,857 0% 6.1% $15,513,455
ORBIMED ADVISORS LLC 1.2% 1,069,147 0% 0.29% $15,288,802
5AM Venture Management, LLC 1.2% 1,050,000 0% 5.2% $15,015,000
Rosalind Advisors, Inc. 1.1% 988,230 -4.7% 5.3% $14,131,689
VANGUARD PORTFOLIO MANAGEMENT LLC 1.1% 971,014 +22% 0% $13,885,500
AMERIPRISE FINANCIAL INC 0.98% 848,410 +100% 0% $12,132,298
DIMENSIONAL FUND ADVISORS LP 0.98% 841,746 +110% 0% $12,035,896

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
24
Headline period
Q2 2026
Rows shown
1-24 of 24
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 621,843 $2,041,188 -$5,969,463 $3.27 23
2026 Q2 92,818,559 $1,327,112,039 +$50,204,790 $14.30 187
2026 Q1 89,144,622 $1,149,112,955 +$43,832,914 $12.89 187
2025 Q4 83,462,381 $1,524,933,420 +$249,855,302 $18.27 166
2025 Q3 69,898,687 $995,227,037 +$20,107,476 $14.24 148
2025 Q2 68,912,118 $648,484,078 -$21,934,653 $9.41 139
2025 Q1 74,070,140 $401,203,753 -$6,558,607 $5.42 149
2024 Q4 74,299,852 $553,357,101 +$114,467,368 $7.45 141
2024 Q3 58,498,731 $476,138,776 -$4,424,916 $7.99 135
2024 Q2 58,415,381 $508,206,601 -$17,769,473 $8.70 148
2024 Q1 55,009,467 $1,137,046,639 +$106,318,844 $20.67 161
2023 Q4 49,565,894 $1,145,491,759 +$422,510,894 $23.11 138
2023 Q3 33,709,262 $269,337,991 +$16,845,118 $7.99 98
2023 Q2 31,573,084 $274,685,383 +$22,852,995 $8.70 82
2023 Q1 29,111,970 $85,592,348 -$1,206,242 $2.94 66
2022 Q4 29,377,926 $102,818,972 -$13,441,865 $3.50 72
2022 Q3 30,106,241 $238,140,639 -$883,849 $7.91 82
2022 Q2 30,200,779 $237,683,742 -$3,357,027 $7.87 78
2022 Q1 30,440,222 $369,919,357 +$7,173,181 $12.15 78
2021 Q4 29,839,293 $365,363,130 +$94,551,507 $12.24 83
2021 Q3 22,128,108 $230,547,815 +$14,765,407 $10.42 61
2021 Q2 20,739,059 $186,447,743 +$7,944,014 $8.99 59
2021 Q1 19,642,118 $199,571,620 +$124,369,380 $10.16 58
2020 Q4 7,703,318 $50,684,935 +$50,684,935 $6.58 31
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .